Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04348110
Other study ID # CS19152
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 17, 2020
Est. completion date December 31, 2020

Study information

Verified date May 2020
Source TCI Co., Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the efficacy of blueberry chewable tablets on Eye Health


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date December 31, 2020
Est. primary completion date July 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Adult men and women over 20 years old - Use 3C products over 6 hours per day - Symptoms of dry eyes or tired eyes - Tear Break-Up Time is 10 seconds less - No history of ocular surgery (strabismus surgery, refractive surgery etc.) Exclusion Criteria: - Have systemic diseases affecting the front surface of the eyes. - Long-term use of drugs or eye drops that affect the condition of the front surface of the eyes - Long-term contact lens wear

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Placebo tablets
consume 2 tablets per day for 8 weeks
Blueberry Chewable Tablets
consume 2 tablets per day for 8 weeks

Locations

Country Name City State
Taiwan Chung Shan Medical University Taichung

Sponsors (1)

Lead Sponsor Collaborator
TCI Co., Ltd.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes of Schirmer's test Schirmer's test determines whether the eye produces enough tears to keep it moist. Units: mm (in 5minutes) 8 weeks
Primary Changes of tear meniscus height Slit lamp Ocular Surface Analyzer is utilized to measure tear meniscus height. Units: mm 8 weeks
Primary Changes of non-invasive tear break-up time (NITBUT) Ocular Surface Analyzer is utilized to measure non-invasive tear break-up time. Units: sec 8 weeks
Primary Tear break-up time (TBUT) Slit lamp ocular Surface Analyzer is utilized to measure fist tear break-up time with slit lamp. Units: sec 8 weeks
Primary Changes of accommodation Speedy-I is utilized to measure the accommodative micro fluctuation test of the ciliary muscle. Units: HFC 8 weeks
Primary Ocular Surface Disease Index (OSDI) The Ocular Surface Disease Index (OSDI) is a 12-item scale for the assessment of symptoms related to dry eye disease and their effect on vision. Units: point 8 weeks
Secondary Changes of eye pressure Eye pressure is measured in millimeters of mercury (mm Hg). 8 weeks
Secondary Changes of Intraocular pressure (IOP) Eye pressure is measured in millimeters of mercury (mm Hg). Units: mmHg 8 weeks
Secondary Changes of Near point of convergence (NPC) RAF rule were initiated in order to normalize NPC. Record as break/recovery. Units: cm 8 weeks
Secondary Changes of Stereo vision The Randot Stereotest is utilized to evaluate the depth perception. Units: sec 8 weeks
Secondary Changes of binocular motor fusion The test is utilized to evaluate to assess binocular motor fusion, specifically the extent to which a patient can maintain binocular single vision (BSV) in the presence of increasing vergence demands. Units: prism 8 weeks
Secondary Changes of Amplitude of accommodation (AA) The amplitude of accommodation is the maximum potential increase in optical power that an eye can achieve in adjusting its focus. It refers to a certain range of object distances for which the retinal image is as sharply focused as possible. Units: diopter 8 weeks
Secondary Changes of Amplitude of Flipper facility Vergence facility (VF) was measured by using a prism flipper to evaluate the ability of the fusional vergence at near with +/-2.00 flipper. Units: cpm 8 weeks
Secondary Changes of Fundus photography The fundus is the back of the eye and includes the retina, optic nerve, and retinal blood vessels. 8 weeks
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05948501 - The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss
Recruiting NCT06412393 - Evaluation of Eye Health Benefits of Black Tomato Extract N/A